Page last updated: 2024-11-03

procarbazine and Cerebral Cryptococcosis

procarbazine has been researched along with Cerebral Cryptococcosis in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"The authors present the first case report of a patient with lymphoma who developed disseminated cryptococcal osteomyelitis and meningitis while being treated with the PEP-C (prednisone, etoposide, procarbazine and cyclophosphamide) chemotherapy regimen."3.78Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C. ( Brown, JM; Fan, AC; Felsher, DW; Fischbein, NJ; Howard, W; Hsieh, RW; McClellan, JS; To, CA, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
To, CA1
Hsieh, RW1
McClellan, JS1
Howard, W1
Fischbein, NJ1
Brown, JM1
Felsher, DW1
Fan, AC1
Rajkumar, K1
Rajkumar, T1
Sagar, TG1
Maitreyan, V1
Shanta, V1

Other Studies

2 other studies available for procarbazine and Cerebral Cryptococcosis

ArticleYear
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.
    BMJ case reports, 2012, Sep-07, Volume: 2012

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcus neoformans; Cy

2012
Cryptococcal meningitis in a patient with Hodgkin's lymphoma.
    The Journal of the Association of Physicians of India, 1991, Volume: 39, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Susceptibility; Hod

1991